Global Insulin Pens, Syringes, Pumps and Injectors Industry (2015 to 2030) – Featuring Eli Lilly and Company, Abbott & Arkray Among Others

Dublin, April 07, 2020 (GLOBE NEWSWIRE) — The “Insulin Pens, Syringes, Pumps and Injectors Global Market Opportunities and Strategies to 2030” report has been added to ResearchAndMarkets.com’s offering.Where is the largest and fastest-growing market for the insulin pens, syringes, pumps and injectors market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global insulin pens, syringes, pumps and injectors market report to 2030 report from the publisher answers all these questions and many more.
The global insulin pens, syringes, pumps and injectors market reached a value of nearly $16,148.7 million in 2019, having grown at a compound annual growth rate (CAGR) of 7.42% since 2015, and is expected to grow at a CAGR of 8.71% to nearly $22,553.3 million by 2023. Also, the market is expected to grow to $26,335.1 million in 2025 at a CAGR of 8.06% and to $ 38,137.9 million in 2030 at a CAGR of 7.69%.Eli Lilly and CompanyAbbottArkrayB. Braun Melsungen AGBecton, Dickinson and CompanyBiocon Ltd.DexcomF. Hoffmann-La Roche AGHindustan Syringes & Medical DevicesInsujetInsulet CorporationMedtronic plcNIPRO
For more information about this report visit https://www.researchandmarkets.com/r/fx60jxResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900